A former Gilead Sciences Inc. COO says in new court papers that a lawsuit filed against him by a former aide should be transferred to Ventura County, saying he had no personal or business ties to Los ...

Mount Gilead's boys cross country team won the Division III state championship Saturday morning at Fortress Obetz, plus other ...

The next referendum on Gilead Sciences’ oft-criticized oncology business is approaching. Circle Nov. 5 on your calendars.

AbTherx announced the expansion of a previous agreement with Gilead (GILD) Sciences to develop novel antibody discovery technologies and ...

Gilead Sciences (GILD) concluded the recent trading session at $88.82, signifying a +0.6% move from its prior day's close.

Besides Wall Street's top -and-bottom-line estimates for Gilead (GILD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...

The Supreme Court of California is gearing up to decide an important question for the future of product liability law: Do drug manufacturers have ...

Leerink has upgraded Gilead Sciences (GILD) to outperform, citing the growth outlook for its PrEP medication lenacapavir for ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Gilead Sciences (GILD – Research Report) today and set a price target of ...

We're prioritizing health equity for patients across the cancer care continuum. Our Gilead Oncology Grant supports 22 U.S. organizations with $3.15 million to provide resources for people affected by ...

Mount Gilead senior Will Baker talks about winning a Division III regional championship in boys cross country Saturday at ...

PICKERINGTON — Mount Gilead proved an old cross country axiom true: Every place, every second and every step counts. During ...